OncoMatch/Clinical Trials/NCT06511037
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Is NCT06511037 recruiting? Yes, currently enrolling (Jun 2026). This Early Phase 1 trial studies Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging for gastrointestinal cancer.
Treatment: Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging — This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Colorectal Cancer
Gastric Cancer
Hepatocellular Carcinoma
Pancreatic Cancer
Cholangiocarcinoma
Esophageal Carcinoma
Ovarian Cancer
Prior therapy
Cannot have received: pafolacianine (cytalux, pafolacianine)
Cannot have received: investigational agent
Lab requirements
Kidney function
eGFR <50 mL/min/1.73m2 excluded
Liver function
ALT, AST, ALP, or total bilirubin >3x ULN excluded
Impaired renal function defined as eGFR <50 mL/min/1.73m2; Impaired liver function defined as values >3x the upper limit of normal (ULN) for alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), or total bilirubin; Clinically significant abnormalities on ECG
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Chao Family Comprehensive Cancer Center, University of California, Irvine · Orange, California
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT06511037 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior pafolacianine, investigational agent disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages